Athyrium is a life science-focused investment firm that specializes in providing financial services to companies in the healthcare sector, including biotechnology and medical devices.

Jeffrey A Ferrell

Athyrium

Athyrium Capital is a specialized asset management company with a focus on the global healthcare sector. Athyrium invests in a wide range of financial instruments including royalties, structured credit, and equities as well as select special situations.

Zealand Pharma

Kala Pharmaceuticals

Apollo Endosurgery

Biora Therapeutics

Sound Physicians

VillageMD

BioCryst Pharmaceuticals

Clover Health

Dermira

Halozyme Therapeutics

OptiNose

Travere Therapeutics

Revance Therapeutics

Portola Pharmaceuticals

Puma Biotechnology

Athyrium Capital Management, LP

Metric
Company Name	Athyrium
Symbol
MSH ID	COM:ATHYRIUM
Market	PRIVATE
Sector	Financial Services & Finance
Industry	Investment Management
Country	US
Stage
Employee Count	27
Website	athyrium.com
LinkedIn	athyrium-capital-management-llc
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:ATHYRIUM

Athyrium

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue